U.S. pharma large copyright scrapped two experimental weight loss tablets past yr—a as soon as-each day tablet, lotiglipron, as a result of elevated liver enzymes in addition to a two times-day by day tablet, danuglipron, as a consequence of robust Unintended effects—but CEO Albert Bourla has said the company is set to “play and gain” in th